Carrier-mediated hepatic uptake of the cationic cyclopeptide, octreotide, in rats: Comparison between in vivo and in vitro

Drug Metabolism and Disposition

Volumn 25, Issue 5, 1997, Pages 536-543

  Yamada, Tadashi ^b   Niinuma, Kayoko ^b   Lemaire, Michel ^b   Terasaki, Tetsuya ^b   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPEPTIDE; DIBROMOSULFOPHTHALEIN; OCTREOTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILIARY EXCRETION; CELL CULTURE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG EXCRETION; DRUG METABOLISM; DRUG UPTAKE; HYPERBILIRUBINEMIA; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ANIMALS; BILE; BIOLOGICAL TRANSPORT; CELLS, CULTURED; LIVER; MALE; OCTREOTIDE; P-AMINOHIPPURIC ACID; RATS; RATS, INBRED STRAINS; SPECIES SPECIFICITY; SULFOBROMOPHTHALEIN; TAUROCHOLIC ACID; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0030909156     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. W. Bauer, U. Briner, W. Doepfner, R. Haller, R, Huguenin, P. Marbach, T. J. Petcher, and J. Pless: SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 32, 1133-1140, (1982).
2. S. W. J. Lamberts, P. Utterlinden, L. Verschoor, K. J. Van Dogen, and E. del Pozo: Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. N. Engl. J. Med. 313, 1576-1580 (1985).
3. S. M. Wood, M. E. Kraenzlim, T. E. Adrian, and S. R. Bloom: Treatment of patients with pancreatic endocrine tumors using a new long-acting somatostatin analogue. Symptomatic and peptide responses. Gut 26, 438-444 (1985).
4. H. Nirei, K. Hamada, M. Shoubo, K. Sogabe, Y. Notsu, and T. Ono: An endothelin ETA receptor antagonist. FR139317, ameliorates cerebral vasospasm in dog. Life Sci. 52, 1869-1874 (1993).
5. M. Nisikibe, S. Tsuchida, M. Okada, T. Fukuroda, K. Shimamoto, M. Yano, K. Ishikawa, and F. Ikemoto: Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model. Life Sci. 52, 717-724 (1993).
6. A. Ondetti and D. W. Cushman: Inhibition of the renin-angiotensin system. A new approach to the therapy of hypertension. J. Med. Chem. 24, 355-361 (1981).
7. M. Berelowitz, S. Kronheim, B. Pimstone, and B. Shapiro: Somatostatin-like immunoreactivity in rat blood: characterization, regional differences, and responses to oral and intravenous glucose. J. Clin. Invest. 61, 1410-1414 (1978).
8. S. M. Cathapermal, M. L. Foegh, C. S. Rau, and P. W. Ramwell: Disposition and tissue distribution of angiopeptin in rat. Drug Metab. Dispos. 19, 735-739 (1991).
9. J. C. Greenfield, K. J. Cook, and I. A. O'Leary: Disposition, metabolism, and excretion of U-71038, a novel renin inhibitor peptide, in the rat. Drug Metab. Dispos. 17, 518-525 (1989).
10. A. Blom, K. Keulemans, and D. K. F. Meijer: Transport of dibromosulfophthalein by isolated rat hepatocytes. Biochem. Pharmacol. 30, 1809-1816 (1981).
11. A. Tsuji, T. Terasaki, T. Takanosu, I. Tamai, and E. Nakashima: Uptake of benzylpenicillin, cefpiramide and cefazolin by freshly isolated rat hepatocytes. Biochem. Pharmacol. 35, 151-158 (1986).
12. +-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. Am. J. Physiol. 264, G36-G44 (1993).
13. P. J. Meier: Transport polarity of hepatocytes. Semin. Liver Dis. 8, 293-307 (1988).
14. +-dependent taurocholate uptake in basolateral (sinusoidal) rat liver plasma membrane vesicles. J. Pharmacol. Exp. Ther. 250, 301-308 (1989).
15. D. K. F. Meijer, W. E. M. Mol, M. Muller, and G. Kurz: Carrier-mediated transport in the hepatic distribution and elimination of drugs with special reference to the category of organic cations. J. Pharmacokinet. Biopharmacol. 18, 35-70 (1990).
16. G. Fricker, V. Dubst, D. Schwab, C. Brouns, and C. Thiele: Heterogeneity in hepatic transport of somatostatin analog octapeptides. Hepatology 20, 191-200 (1994).
17. T. Terasaki, H. Mizukuchi, C. Itoho, I. Tamai, M. Lemaire, and A. Tsuji: Hepatic uptake of octreotide, a long-acting somatostatin analogue, via a bile acid transport system. Pharm. Res. 12, 11-16 (1995).
18. K. Ziegler and A. Seeberger: Hepatocellular transport of cyclosomatostatins: evidence for a carrier system related to the multispecific bile acid transporter. Biochem. Biophys. Acta 1061, 287-296 (1991).
19. A. Bertrams and K. Ziegler: Hepatocellular uptake of peptide by bile acid transporter: relationship of carrier-mediated transport of linear peptides with renin-inhibiting activity to multispecific bile acid carriers. Biochem. Biophys. Acta 1091, 337-348 (1991).
20. A. Bertrams and K. Ziegler: New substrates of the multispecific bile acid transporter in liver cells: interference of some linear renin inhibiting peptides with transport protein(s) for bile acids. Biochem. Biophys. Acta 1073, 213-220 (1991)
21. A. Seeberger and K. Ziegler: Hepatocellular uptake of peptides. II. Interactions between hydrophilic linear renin-inhibiting peptides and transport system for endogenous substrates in liver cells. Biochem. Pharmacol. 45, 917-925 (1993).
22. K. Ziegler, W. Lins, and M. Frimmer: Hepatocellular uptake of peptides. I. Carrier-mediated uptake of hydrophilic linear peptides with renin inhibitory activity into isolated rat liver cells. Biochem. Pharmacol. 45, 909-916 (1993).
23. T. Nakamura, A. Hisaka, Y. Sawasaki, Y. Suzuki, T. Fukami, K. Ishikawa, M. Yano, and Y. Sugiyama: Carrier-mediated active transport of BQ-123, a peptidic endotherin antagonist into rat hepatocyte. J. Pharmacol. Exp. Ther. 278, 564-572 (1996).
24. G. J. Gores, L. J. Kost, L. J. Miller, and N. F. RaRusso: Processing of cholecystokinin by isolated liver cells. Am. J. Physiol. 257, G242-G248 (1989).
25. J. B. Pritchard: Luminal and peritubular steps in renal transport p-amin-ohippurate. Biochem. Biophys. Acta 906, 295-308 (1987).
26. M. Lemaire, M. Azria, R. Dannecker, P. Marbach, A. Schweitzer, and G. Maurer: Disposition of sandostatin, a new synthetic somatostatin analogue, in rats. Drug Metab. Dispos. 17, 699-703 (1989).
27. H. Takikawa, N. Sano, T. Narita, T. Uchida, M. Yamanaka, T. Horie, T. Mikarni, and O. Tagaya: Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat. Hepatology 14, 352-360 (1991).
28. K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno: A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharm. Dyn. 4, 879-885 (1981).
29. Y. Kato, H. Sato, M. Ichikawa, H. Suzuki, Y. Sawada, M. Hanano, T. Fuwa, and Y. Sugiyama: Existence of two pathways for the endocytosis epidermal growth factor by rat liver: phenylasineoxide sensitive pathways. Proc. Natl. Acad. Sci. U.S.A. 89, 8507-8511 (1992).
30. H. Sato, Y. Sugiyama, Y. Sawada, T. Iga, T. Fuwa, and M. Hanano: Internalization of EGF in perfused rat liver is independent of the degree of receptor occupancy. Am. J. Physiol. 258, G682-G689 (1990).
31. H. Baur, S. Kasperek, and E. Pfaff: Criteria of viability of isolated liver cells. Hoppe-Seyler's Z. Physiol. Chem. 356, 827-838 (1975).
32. M. Schwenk: Transport system of isolated hepatocytes. Studies on the transport of biliary compounds. Arch. Toxicol. 44, 113-126 (1980).
33. Y. Kato and Y. Sugiyama: Binding, internalization degradation and mitogenic effect of epidermal growth factor in cultured rat hepatocytes. S.T.P. Pharm. Sci. 3, 75-82 (1993).
34. K. S. Pang and M. Rowland: Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. J. Pharmacokinet. Biopharmacol. 5, 625-653 (1977).
35. K. Winkeler, S. Keiding, and T. Tygstrup: "The Liver Quantitative Aspect of Structure and Function" (G. Paumgartner and P. Reisig, eds.), pp. 144-155. Basel, Karger, 1973.
36. R. J. Dedrick, D. S. Zaharko, and R. Lutz: Transport and binding of methotrexate in vivo. J. Pharm. Sci. 62, 662-690 (1973).
37. H. C. Shin, Y. Kato, T. Yamada, K. Niinuma, T. Hisaka, and Y. Sugiyama: Hepatobiliary transport mechanism for the cyclopentapeptide endothelin antagonist, BQ-123. Am. J. Physiol. in press, 1997.
38. K. Sathirakul, H. Suzuki, K. Yasuda, M. Hanano, O. Tagaya, T. Horie, and Y. Sugiyama: Kinetic analysis of hepatobiliary transport of organic anion in Eisai hyperbilirubinemic mutant rats. J. Pharmacol. Exp. Ther. 265, 1301-1312 (1993).
39. H. Shimamura, H. Suzuki, M. Hanano, A. Suzuki, O. Tagaya, T. Horie, and Y. Sugiyama: Multiple systems for the biliary excretion of organic anions in rats: liquiritigenin conjugates as model compounds. J. Pharmacol. Exp. Ther. 271, 370-378 (1994).
40. O. Takenaka, T. Horie, H. Suzuki, and Y. Sugiyama: Different biliary excretion system for glucuronide and sulfate of a model compound; study using Eisai hyperbilirubinemic rats. J. Pharmacol. Exp. Ther. 274, 1362-1369 (1995).
41. T. Yamada, K. Niinuma, M. Lemaire, T. Terasaki, and Y. Sugiyama: Mechanism of tissue distribution and biliary excretion of the cyclic octapeptide, octreotide. J. Pharmacol. Exp. Ther. 279:1357-1364, 1997.
42. M. Yamazaki, H. Suzuki, Y. Sugiyama, T. Iga, and M. Hanano: Uptake of organic anions by isolated rat hepatocytes: a classification in terms of ATP-dependency. J. Hepatol. 14, 41-47 (1992).